Catalent aims to boost drug delivery through industry-academia partnership

- Last updated on GMT

Related tags: Drug delivery, Research, Research and development

Boosting communication between industry and academia is the way to advance drug delivery, says Catalent
Boosting communication between industry and academia is the way to advance drug delivery, says Catalent
Catalent has established a new institute in a bid to advance drug delivery by creating links between industry and academia.

The association – named the Applied Drug Delivery Institute – will provide training programmes, help establish partnerships between universities and business, and will work with regulatory bodies in an effort to solve industry-wide issues.

In a statement, senior VP of research and development (R&D) Kurt Nielsen said: “The mission of the Catalent Applied Drug Delivery Institute is to bring better treatments to market by advancing the development and adoption of applied drug delivery technologies.

Rao Tatapudy, VP of scientific affairs added: “We look forward to a continuous series of successful collaborations as the institute’s activities unfold.”

The firm launched the new organisation during a press conference at AAPS, where we spoke to the programme leaders about the reasons behind the move, the current happenings and what’s to come.

Read the article on next week’s Outsourcing-Pharma.com

Related news

Show more

Related products

show more

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q2 Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Parents as Gatekeepers for Children with Cancer

Parents as Gatekeepers for Children with Cancer

PRA Health Sciences | 08-Jun-2020 | Technical / White Paper

The RACE for Children Act will require new drugs intended for adult cancer treatment to also be studied in pediatric cancers when the molecular target...

Flow Cytometry Services

Flow Cytometry Services

Q2 Solutions | 01-Jun-2020 | Data Sheet

We are an established leader in flow cytometry services for clinical trials. Our technologies and solutions meet the growing global demand for enhanced...

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Related suppliers

Follow us

Products

View more

Webinars